Continued evolution of highly pathogenic avian influenza A (H5N1): updated nomenclature-Reference-Cited by-全球学者库

Continued evolution of highly pathogenic avian influenza A (H5N1): updated nomenclature

Published:2011-10-29 Issue:1 Volume:6 Page:1-5
ISSN:1750-2640
Container-title:Influenza and Other Respiratory Viruses
language:en
Short-container-title:

Author:

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1750-2659.2011.00298.x/fullpdf

Reference14 articles.

1. Continuing progress towards a unified nomenclature for the highly pathogenic H5N1 avian influenza viruses: divergence of clade 2.2 viruses;WHO/OIE/FAO H5N1 Evolution Working Group;Influenza Other Respi Viruses,2009

2. Towards a unified nomenclature system for highly pathogenic avian influenza virus (H5N1);World Health Organization/World Organisation for Animal Health/Food and Agriculture Organization H5N1 Evolution Working Group;Emerg Infec Dis,2008

3. MUSCLE: multiple sequence alignment with high accuracy and high throughput;Edgar;Nucleic Acids Res,2004

4. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0;Tamura;Mol Biol Evol,2007

Cited by 224 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Field and laboratory investigation of highly pathogenic avian influenza H5N6 and H5N8 in Quang Ninh province, Vietnam, 2020 to 2021;Journal of Veterinary Science;2024

2. Highly Pathogenic Avian Influenza A(H5N1) Virus–Induced Mass Death of Wild Birds, Caspian Sea, Russia, 2022;Emerging Infectious Diseases;2023-12

3. The episodic resurgence of highly pathogenic avian influenza H5 virus;Nature;2023-10-18

4. Chicken Immune Responses to Vaccination by the Avian Influenza Subtype H5N1 against Avian Influenza;Makara Journal of Science;2023-09-25

5. Immunogenicity and Cross-Protective Efficacy Induced by an Inactivated Recombinant Avian Influenza A/H5N1 (Clade 2.3.4.4b) Vaccine against Co-Circulating Influenza A/H5Nx Viruses;Vaccines;2023-08-22